分子乳腺成像、二维全视野数字乳腺X线摄影(含或不含断层合成)及合成乳腺X线摄影联合断层合成的获益-辐射风险比比较
该研究基于已发表的获益-风险比方法,比较了分子乳腺成像(MBI)、二维全视野数字乳腺X线摄影(FFDM)、二维FFDM联合合成乳腺X线摄影及二维FFDM联合断层合成在40岁起10年间隔内的获益-风险比,并考虑了乳腺压迫厚度和筛查体位的影响。结果显示,MBI的获益-风险比在多数情况下低于乳腺X线摄影,但在40-59岁、乳腺压迫厚度至少80 mm及每侧乳腺4或5个体位筛查时可能相当或更优;断层合成联合合成乳腺X线摄影的获益-风险比优于联合二维FFDM。
要点
- MBI的获益-风险比多数情况下低于乳腺X线摄影,但在特定人群和条件下可能相当或更优。
- 断层合成联合合成乳腺X线摄影的获益-风险比优于联合二维FFDM。
- 乳腺压迫厚度和筛查体位数量影响获益-风险比的比较结果。
核心结论
- 在考虑乳腺X线摄影技术、乳腺压迫厚度和年龄变化后,MBI的获益-风险比处于乳腺X线摄影的较低范围内;合成乳腺X线摄影联合断层合成的获益-风险比优于断层合成联合二维FFDM。
研究设计与样本
- 仅使用先前发表的估计值,因此本研究免于机构审查委员会批准的要求;比较了MBI、单独二维FFDM、二维FFDM联合合成乳腺X线摄影及二维FFDM联合断层合成在40岁起10年间隔内的获益-风险比,涵盖2、4、5个体位筛查乳腺X线摄影及20-29 mm、50-59 mm、80-89 mm的乳腺压迫厚度。
诊断标准与关键数值
- 获益-风险比计算为10年间隔内避免的乳腺癌死亡数与筛查导致的寿命损失数之比;筛查乳腺X线摄影的获益-风险比中心估计范围为3至179,MBI为5至9。
临床应用与阅片要点
- 对于40-59岁且乳腺压迫厚度至少80 mm的女性,或每侧乳腺进行4或5个体位乳腺X线摄影筛查的女性,MBI可能以相当或更优的获益-风险比进行。
局限性
- 仅使用先前发表的估计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To apply previously published benefit-to-risk ratio methods for mammography and molecular breast imaging (MBI) risk estimates to an expanded range of mammographic screening techniques, compressed breast thicknesses, and screening views.
MATERIALS AND METHODS: Only previously published estimates were used; therefore, this study was exempt from the requirement to obtain institutional review board approval. Benefit-to-risk ratios were calculated as the ratio of breast cancer deaths averted and lives lost to screening over 10-year intervals starting at age 40 years for MBI, two-dimensional (2D) full-field digital mammography (FFDM) alone, 2D FFDM with synthetic mammography, and 2D FFDM with tomosynthesis for two-, four-, and five-view screening mammography and compressed breast thicknesses of 20-29 mm, 50-59 mm, and 80-89 mm.
RESULTS: Central estimates of the benefit-to-risk ratios ranged from 3 to 179 for screening mammography and from 5 to 9 for MBI. Benefit-to-risk ratios for MBI were inferior to those for mammography for most scenarios, but MBI may be performed at an equal or superior benefit-to-risk ratio for women aged 40-59 years with a compressed breast thickness of at least 80 mm and for those undergoing mammographic screening examinations with four or five views per breast. The benefit-to-risk ratios across all ages with use of tomosynthesis plus 2D FFDM as a screening examination were 45% lower than those for tomosynthesis plus synthetic mammography.
CONCLUSION: Benefit-to-risk ratios for MBI are within the lower range of those for mammography when accounting for variation in mammography technique, compressed breast thickness, and age. Benefit-to-risk ratios of synthetic mammography plus tomosynthesis are superior to those of tomosynthesis plus 2D FFDM.Keywords: Breast, Mammography, Molecular Imaging, Molecular Imaging-Cancer, Radiation Safety, Radionuclide Studies, Screening, Tomosynthesis© RSNA, 2019See also the commentary by Hruska in this issue.
引用
- Brown M, Covington MF. Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis. Radiol Imaging Cancer. 2019. PMID: 33778669. doi:10.1148/rycan.2019190005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。